Back to Search Start Over

Neuraminidase is a host-directed approach to regulate neutrophil responses in sepsis and COVID-19.

Authors :
de Oliveira Formiga R
Amaral FC
Souza CF
Mendes DAGB
Wanderley CWS
Lorenzini CB
Santos AA
Antônia J
Faria LF
Natale CC
Paula NM
Silva PCS
Fonseca FR
Aires L
Heck N
Starick MR
Queiroz-Junior CM
Santos FRS
de Souza FRO
Costa VV
Barroso SPC
Morrot A
Van Weyenbergh J
Sordi R
Alisson-Silva F
Cunha FQ
Rocha EL
Chollet-Martin S
Hurtado-Nedelec MM
Martin C
Burgel PR
Mansur DS
Maurici R
Macauley MS
Báfica A
Witko-Sarsat V
Spiller F
Source :
British journal of pharmacology [Br J Pharmacol] 2023 Jun; Vol. 180 (11), pp. 1460-1481. Date of Electronic Publication: 2023 Jan 13.
Publication Year :
2023

Abstract

Background and Purpose: Neutrophil overstimulation plays a crucial role in tissue damage during severe infections. Because pathogen-derived neuraminidase (NEU) stimulates neutrophils, we investigated whether host NEU can be targeted to regulate the neutrophil dysregulation observed in severe infections.<br />Experimental Approach: The effects of NEU inhibitors on lipopolysaccharide (LPS)-stimulated neutrophils from healthy donors or COVID-19 patients were determined by evaluating the shedding of surface sialic acids, cell activation, and reactive oxygen species (ROS) production. Re-analysis of single-cell RNA sequencing of respiratory tract samples from COVID-19 patients also was carried out. The effects of oseltamivir on sepsis and betacoronavirus-induced acute lung injury were evaluated in murine models.<br />Key Results: Oseltamivir and zanamivir constrained host NEU activity, surface sialic acid release, cell activation, and ROS production by LPS-activated human neutrophils. Mechanistically, LPS increased the interaction of NEU1 with matrix metalloproteinase 9 (MMP-9). Inhibition of MMP-9 prevented LPS-induced NEU activity and neutrophil response. In vivo, treatment with oseltamivir fine-tuned neutrophil migration and improved infection control as well as host survival in peritonitis and pneumonia sepsis. NEU1 also is highly expressed in neutrophils from COVID-19 patients, and treatment of whole-blood samples from these patients with either oseltamivir or zanamivir reduced neutrophil overactivation. Oseltamivir treatment of intranasally infected mice with the mouse hepatitis coronavirus 3 (MHV-3) decreased lung neutrophil infiltration, viral load, and tissue damage.<br />Conclusion and Implications: These findings suggest that interplay of NEU1-MMP-9 induces neutrophil overactivation. In vivo, NEU may serve as a host-directed target to dampen neutrophil dysfunction during severe infections.<br /> (© 2022 British Pharmacological Society.)

Details

Language :
English
ISSN :
1476-5381
Volume :
180
Issue :
11
Database :
MEDLINE
Journal :
British journal of pharmacology
Publication Type :
Academic Journal
Accession number :
36526272
Full Text :
https://doi.org/10.1111/bph.16013